PulmoCORE Panel 4 near me in Varanasi

pulmoCORE Panel 4 analyzes the genetic abnormalities in EGFR, ALK, ROS-1 and BRAF genes. Identification of genetic mutations in such genes are associated with non-small cell lung cancer. Apart from identifying genetic mutations, the panel also uses PD - L1 (SP263 Ventana) assays which identify patients who are most likely to respond to specific therapies related to NSCLC so that  doctors can make timely diagnostic decisions and therapeutic choices. Genetic information from this panel can also be useful in early detection of NSCLC if there are risk factors. Early detection of cancer is the most important step in ensuring a favorable prognosis, and timely intervention can reduce the risk of developing cancer.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.